News for China National Medicines Corporation Ltd. (600511.SS)

Published at

Dec 8, 2023 10:09 PM

by marketscreener.com

positive

positive

CASI Pharmaceuticals : Enters into an Exclusive Distribution Agreement - Form 6-K -December 08, 2023 at 04:09 pm EST

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER ...

CASI 600511.SS

Read more →
Published at

Jan 15, 2021 8:57 AM

by cnbc.com

positive

positive

Two senior managers from one of China's top vaccine companies have resigned

Sinopharm, a state-owned giant behind China's coronavirus vaccine development, announced its chairman left the board as of Tuesday.

600511.SS

Read more →